Literature DB >> 22105886

Hydroxyureas as noncovalent proteasome inhibitors.

Nerea Gallastegui1, Philipp Beck, Marcelino Arciniega, Robert Huber, Stefan Hillebrand, Michael Groll.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22105886     DOI： 10.1002/anie.201106010

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  13 in total

Review 1.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

2.  Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor.

Authors:  Sanil Bhatia; Viktoria Krieger; Michael Groll; Jeremy D Osko; Nina Reßing; Heinz Ahlert; Arndt Borkhardt; Thomas Kurz; David W Christianson; Julia Hauer; Finn K Hansen
Journal:  J Med Chem       Date:  2018-11-08       Impact factor: 7.446

3.  Oxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.

Authors:  Sevil Ozcan; Aslamuzzaman Kazi; Frank Marsilio; Bin Fang; Wayne C Guida; John Koomen; Harshani R Lawrence; Saïd M Sebti
Journal:  J Med Chem       Date:  2013-05-13       Impact factor: 7.446

4.  Immunoproteasome β5i-Selective Dipeptidomimetic Inhibitors.

Authors:  Pradeep K Singh; Hao Fan; Xiuju Jiang; Lei Shi; Carl F Nathan; Gang Lin
Journal:  ChemMedChem       Date:  2016-08-25       Impact factor: 3.466

5.  Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity.

Authors:  Aslamuzzaman Kazi; Sevil Ozcan; Awet Tecleab; Ying Sun; Harshani R Lawrence; Saïd M Sebti
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

6.  Substituted quinolines as noncovalent proteasome inhibitors.

Authors:  Tanner J McDaniel; Theresa A Lansdell; Amila A Dissanayake; Lauren M Azevedo; Jacob Claes; Aaron L Odom; Jetze J Tepe
Journal:  Bioorg Med Chem       Date:  2016-04-02       Impact factor: 3.641

Review 7.  Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system.

Authors:  Dennis L Buckley; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-23       Impact factor: 16.823

8.  Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.

Authors:  Bruno O Villoutreix; Abdel-Majid Khatib; Yan Cheng; Maria A Miteva; Xavier Maréchal; Joëlle Vidal; Michèle Reboud-Ravaux
Journal:  Oncotarget       Date:  2017-02-07

9.  Inhibition of human and yeast 20S proteasome by analogues of trypsin inhibitor SFTI-1.

Authors:  Dawid Dębowski; Michał Pikuła; Marta Lubos; Paulina Langa; Piotr Trzonkowski; Adam Lesner; Anna Łęgowska; Krzysztof Rolka
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

Review 10.  The 26S proteasome is a multifaceted target for anti-cancer therapies.

Authors:  Tatyana A Grigoreva; Vyacheslav G Tribulovich; Alexander V Garabadzhiu; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.